This HTML5 document contains 107 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58096215
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована в жовтні 2018 article artículu científicu article scientifique publié en 2018 im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q58096215-5E705322-3C7E-4AF4-81C8-19226B1E033B
wdt:P577
2018-10-30T00:00:00Z
p:P407
wds:Q58096215-ACACC643-CF2B-418A-B649-B0CF6F12ABA2
wdt:P407
wd:Q1860
p:P2860
wds:Q58096215-E80D9DD4-0AFB-4834-AC3F-620205353D91 wds:Q58096215-EF44A1A2-7E60-4DF3-B65B-ADCEE0A7D6E8 wds:Q58096215-F0667B98-DE25-40C0-A9E1-1A93577BB0C2 wds:Q58096215-FCBF8567-7508-4829-9B90-F164FABE1984 wds:Q58096215-DF36B181-3367-40B9-A281-440AD78D830F wds:Q58096215-E7DDC0D9-DC9C-4B6A-A3B2-FE4F90D2E670 wds:Q58096215-FEFF39C4-4BAC-47A1-A83E-DAEA327D842F wds:Q58096215-02769FA9-467C-474E-8D75-3B255B76C536 wds:Q58096215-07B2A114-00D0-4395-B8A5-56FDC1F49239 wds:Q58096215-0B670F0A-E417-46F9-8725-6FA07E030E45 wds:Q58096215-0D40917B-F3D1-4A57-B86D-5128B0168DFE wds:Q58096215-00CF4C2F-09B7-4567-B599-D2D0A6BB4A92 wds:Q58096215-25F62066-80E3-467E-A1A1-0184B2C53CB9 wds:Q58096215-272346F4-4CED-4367-B11D-0701C1A72494 wds:Q58096215-2DFB5AA9-07B8-4FB6-8F03-13EA90EA6076 wds:Q58096215-350FC4C4-BC87-452D-9561-CEED25884B53 wds:Q58096215-0F4EAD4E-3A04-4772-A62E-A4D5E1E322E3 wds:Q58096215-12C8605D-1DFC-4A13-AA12-213601E3C345 wds:Q58096215-166221CD-DE6E-4D21-876A-BACBA137795F wds:Q58096215-1F9ED0EB-AAC4-4438-9456-D2B798E881D3 wds:Q58096215-6ED479C3-71D6-4F3F-A020-1B9F7EC661C6 wds:Q58096215-81B0C8E2-BF5D-4FD5-B35C-E29D30E1B30B wds:Q58096215-50A9EAFD-5368-4D6A-A3A1-B598466E5EA3 wds:Q58096215-5742050E-4371-424B-9F79-673335193F02 wds:Q58096215-95025B2A-DE37-4197-A071-D5168CAA97EE wds:Q58096215-82E0B8C4-C4C3-48DE-A676-EE17A82BF0AE wds:Q58096215-8F587AE1-197B-456C-BE23-FBD30DB2FFFE wds:Q58096215-9371840B-E0FD-40AE-A277-88DBC5CD81BC wds:Q58096215-C86C4A17-C6F5-4C26-81AB-2D929F6C4C28 wds:Q58096215-D6B430CF-720C-416C-976E-663BC8C12346 wds:Q58096215-DE56A3FE-DEED-4C03-AA2A-1188931A683A wds:Q58096215-AF57702A-96BA-455F-B1C3-A72B89C7A4D0 wds:Q58096215-B4CD5EC5-F885-45DC-AD6A-D1167224E508 wds:Q58096215-B5615CD1-5ED0-4438-B657-96A339E6CAF8
wdt:P2860
wd:Q39038674 wd:Q38692511 wd:Q28385712 wd:Q50198076 wd:Q30847275 wd:Q42677492 wd:Q46140700 wd:Q38832525 wd:Q52622918 wd:Q36234396 wd:Q88339525 wd:Q48655131 wd:Q50854464 wd:Q88708636 wd:Q46365334 wd:Q36277022 wd:Q37065978 wd:Q33590850 wd:Q50592090 wd:Q80768425 wd:Q38263152 wd:Q39149201 wd:Q50128100 wd:Q46006799 wd:Q47579286 wd:Q28386602 wd:Q34533164 wd:Q36233987 wd:Q38932454 wd:Q40244899 wd:Q52674273 wd:Q57207899 wd:Q38636741 wd:Q50115874
p:P2093
wds:Q58096215-A4FF37A8-FBC6-4D4F-997C-4F7DD5539176 wds:Q58096215-AE3FFD44-2402-459E-9763-5BBDE7E809EF
wdt:P2093
Arvind Dasari Axel Grothey
rdfs:label
Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies
skos:prefLabel
Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies
schema:name
Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies
p:P50
wds:Q58096215-DFA1BEFE-D675-46A0-B5AD-F1A3AB5ADFC4
wdt:P50
wd:Q51789838
p:P1476
wds:Q58096215-7ADC12D4-60E2-4596-93B4-FEE7D6955E8D
wdt:P1476
Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies
p:P304
wds:Q58096215-8030B86B-282A-4A7F-9BB0-20902E9114D4
wdt:P304
JCO2018789032
p:P31
wds:Q58096215-E4B9A6F7-BE01-4ED4-A391-5E26944C2866
wdt:P31
wd:Q13442814
p:P698
wds:Q58096215-D5893F1B-925D-4A25-9EE1-F070F8B86D27
wdtn:P698
n10:30376428
wdt:P698
30376428
p:P1433
wds:Q58096215-85BC019F-14F8-4FA6-B1A9-838CB52CDB3E
wdt:P1433
wd:Q400292
p:P356
wds:Q58096215-A51C3B92-8870-47FF-9956-0A39D8C105BE
wdtn:P356
n9:JCO.2018.78.9032
wdt:P356
10.1200/JCO.2018.78.9032
p:P932
wds:Q58096215-4F5ADF36-D97D-431B-93B9-0FA2E3057FBD
wdt:P932
6286158